The National Institute on Aging and the Alzheimer’s Association have proposed revised clinical guidelines that would designate seven major stages of the brain disease. The first two would be for people who have no symptoms but may be at higher risk for Alzheimer’s at some time in the future.
These technical guidelines, which would update a 2018 version, could have enormous, and conflicting, implications for drug research, health care costs, access to insurance, and the psychological well-being of older adults.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased